vs
ABVC BIOPHARMA, INC.（ABVC）与阿帕奇（LASE）财务数据对比。点击上方公司名可切换其他公司
阿帕奇的季度营收约是ABVC BIOPHARMA, INC.的1.2倍（$919.3K vs $796.0K），ABVC BIOPHARMA, INC.净利率更高（-256.6% vs -506.4%，领先249.8%），ABVC BIOPHARMA, INC.同比增速更快（104.5% vs 28.3%），过去两年ABVC BIOPHARMA, INC.的营收复合增速更高（1041.5% vs -3.9%）
ABVC生物制药是一家处于临床阶段的生物制药企业，专注于开发肿瘤、眼科、中枢神经系统疾病等领域的创新治疗方案，业务覆盖北美及亚洲主要市场，多款自研候选药物正处于临床试验推进阶段。
IPG光子公司是光纤激光器制造商，研发并商业化推广光纤激光器产品，其产品广泛应用于材料加工、医疗、电信等多个领域，目前在美国、德国、俄罗斯和意大利均设有生产基地。
ABVC vs LASE — 直观对比
营收规模更大
LASE
是对方的1.2倍
$796.0K
营收增速更快
ABVC
高出76.2%
28.3%
净利率更高
ABVC
高出249.8%
-506.4%
两年增速更快
ABVC
近两年复合增速
-3.9%
损益表 — Q3 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $796.0K | $919.3K |
| 净利润 | $-2.0M | $-4.7M |
| 毛利率 | 100.0% | -20.1% |
| 营业利润率 | -246.8% | -350.0% |
| 净利率 | -256.6% | -506.4% |
| 营收同比 | 104.5% | 28.3% |
| 净利润同比 | -417.4% | -186.5% |
| 每股收益（稀释后） | $-0.09 | $-0.27 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ABVCLASE
| Q3 25 | $796.0K | $919.3K | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | — | $2.3M | ||
| Q4 24 | $2.0K | $1.3M | ||
| Q3 24 | $389.3K | $716.7K | ||
| Q2 24 | $117.1K | $623.4K | ||
| Q1 24 | $1.2K | $743.0K | ||
| Q4 23 | $2.2K | $994.6K |
净利润ABVCLASE
| Q3 25 | $-2.0M | $-4.7M | ||
| Q2 25 | — | $-1.8M | ||
| Q1 25 | — | $-1.7M | ||
| Q4 24 | — | $586.4K | ||
| Q3 24 | $-394.8K | $-1.6M | ||
| Q2 24 | $-942.3K | $-934.3K | ||
| Q1 24 | $-2.8M | $-545.7K | ||
| Q4 23 | — | $-486.6K |
毛利率ABVCLASE
| Q3 25 | 100.0% | -20.1% | ||
| Q2 25 | — | 53.5% | ||
| Q1 25 | — | 49.8% | ||
| Q4 24 | 100.0% | 13.3% | ||
| Q3 24 | 99.9% | 85.0% | ||
| Q2 24 | 99.8% | 50.6% | ||
| Q1 24 | 77.0% | 51.9% | ||
| Q4 23 | — | 84.5% |
营业利润率ABVCLASE
| Q3 25 | -246.8% | -350.0% | ||
| Q2 25 | — | -37.0% | ||
| Q1 25 | — | -68.7% | ||
| Q4 24 | — | -255.1% | ||
| Q3 24 | -77.7% | -238.0% | ||
| Q2 24 | -734.2% | -149.4% | ||
| Q1 24 | -235539.8% | -73.8% | ||
| Q4 23 | — | -88.4% |
净利率ABVCLASE
| Q3 25 | -256.6% | -506.4% | ||
| Q2 25 | — | -68.3% | ||
| Q1 25 | — | -73.4% | ||
| Q4 24 | — | 45.7% | ||
| Q3 24 | -101.4% | -226.8% | ||
| Q2 24 | -804.4% | -149.9% | ||
| Q1 24 | -235203.2% | -73.4% | ||
| Q4 23 | — | -48.9% |
每股收益（稀释后）ABVCLASE
| Q3 25 | $-0.09 | $-0.27 | ||
| Q2 25 | — | $-0.12 | ||
| Q1 25 | — | $-0.12 | ||
| Q4 24 | — | $0.06 | ||
| Q3 24 | $-0.03 | $-0.13 | ||
| Q2 24 | $-0.08 | $-0.09 | ||
| Q1 24 | $-0.29 | $-0.06 | ||
| Q4 23 | — | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $257.2K | $3.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $12.1M | $4.1M |
| 总资产 | $21.2M | $17.5M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ABVCLASE
| Q3 25 | $257.2K | $3.6M | ||
| Q2 25 | — | $78.5K | ||
| Q1 25 | — | $179.1K | ||
| Q4 24 | $313.1K | $533.9K | ||
| Q3 24 | $208.2K | $2.1M | ||
| Q2 24 | $200.0K | $2.7M | ||
| Q1 24 | $106.4K | $5.2M | ||
| Q4 23 | $139.5K | $6.2M |
股东权益ABVCLASE
| Q3 25 | $12.1M | $4.1M | ||
| Q2 25 | — | $4.3M | ||
| Q1 25 | — | $6.8M | ||
| Q4 24 | $1.2M | $10.2M | ||
| Q3 24 | $1.6M | $9.7M | ||
| Q2 24 | $1.8M | $10.3M | ||
| Q1 24 | $1.7M | $12.4M | ||
| Q4 23 | $1.6M | $13.9M |
总资产ABVCLASE
| Q3 25 | $21.2M | $17.5M | ||
| Q2 25 | — | $14.9M | ||
| Q1 25 | — | $16.0M | ||
| Q4 24 | $7.5M | $17.2M | ||
| Q3 24 | $7.8M | $10.6M | ||
| Q2 24 | $8.0M | $11.1M | ||
| Q1 24 | $8.0M | $13.6M | ||
| Q4 23 | $7.8M | $15.1M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-964.7K | $763.1K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ABVCLASE
| Q3 25 | $-964.7K | $763.1K | ||
| Q2 25 | — | $-1.0M | ||
| Q1 25 | — | $-1.2M | ||
| Q4 24 | $-1.8M | $-6.5M | ||
| Q3 24 | $60.2K | $632.7K | ||
| Q2 24 | $-211.4K | $-2.4M | ||
| Q1 24 | $-955.8K | $-866.3K | ||
| Q4 23 | $-4.2M | $-2.0M |
自由现金流ABVCLASE
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $589.6K | ||
| Q2 24 | — | $-2.4M | ||
| Q1 24 | — | $-1.0M | ||
| Q4 23 | $-4.2M | — |
自由现金流率ABVCLASE
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 82.3% | ||
| Q2 24 | — | -388.0% | ||
| Q1 24 | — | -136.9% | ||
| Q4 23 | -194367.2% | — |
资本支出强度ABVCLASE
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 6.0% | ||
| Q2 24 | — | 5.1% | ||
| Q1 24 | — | 20.3% | ||
| Q4 23 | 979.3% | — |
现金转化率ABVCLASE
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -11.11× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
